Surrozen, Inc./DE
Surrozen, Inc./DE
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 102 | 107 | 89 | 81 | 90 | 102 | 35 | 31 | 38 | 27 | 36 | 34 | |||||
Accounts Receivable Net Current | 5 | 5 | 0 | 2 | 2 | 2 | 2 | 12 | 2 | 2 | 2 | 2 | |||||
Marketable Securities Current | - | - | - | - | - | - | - | - | - | - | 0 | 9 | |||||
Accounts Receivable- Related Party | - | - | 3 | 1 | 1 | 1 | 1 | - | - | - | - | - | |||||
Prepaid Expense And Other Assets Current | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | |||||
Assets Current | 109 | 114 | 92 | 86 | 94 | 106 | 39 | 45 | 42 | 32 | 41 | 48 | |||||
Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 2 | 2 | |||||
Operating Lease Right Of Use Asset | 5 | 6 | 6 | 6 | 7 | 7 | 8 | 1 | 1 | 2 | 2 | 2 | |||||
Restricted Cash Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | |||||
Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | |||||
Assets | 116 | 121 | 99 | 94 | 103 | 115 | 48 | 48 | 45 | 37 | 46 | 54 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |||||
Accrued Liabilities Current | 6 | 7 | 8 | 5 | 4 | 9 | 5 | 4 | 4 | 3 | 4 | 4 | |||||
Operating Lease Liability Current | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 3 | 2 | 2 | |||||
Liabilities Current | 9 | 10 | 10 | 7 | 6 | 11 | 7 | 6 | 6 | 6 | 7 | 7 | |||||
Operating Lease Liability Noncurrent | 4 | 5 | 5 | 6 | 6 | 7 | 7 | 0 | 0 | 0 | 1 | 2 | |||||
Derivative Liabilities | 196 | 236 | 159 | 52 | 11 | 42 | 0 | - | - | - | - | - | |||||
Liabilities | 334 | 399 | 286 | 118 | 56 | 109 | 70 | 42 | 39 | 7 | 8 | 8 | |||||
Stockholders Equity | |||||||||||||||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 386 | 377 | 340 | 321 | 320 | 318 | 264 | 263 | 262 | 261 | 260 | 258 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Retained Earnings Accumulated Deficit | -605 | -655 | -527 | -344 | -272 | -312 | -285 | -257 | -256 | -231 | -222 | -213 | |||||
Stockholders Equity | -219 | -278 | -188 | -24 | 47 | 6 | -21 | 6 | 6 | 30 | 38 | 46 | |||||
Liabilities And Stockholders Equity | 116 | 121 | 99 | 94 | 103 | 115 | 48 | 48 | 45 | 37 | 46 | 54 | |||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | |||||
Common Stock Shares Issued | 12 | 11 | 10 | 9 | 9 | 8 | 3 | 3 | 3 | 2 | 2 | 2 | |||||
Shares Outstanding | 12 | 11 | 10 | 9 | 9 | 8 | 3 | 3 | 3 | 2 | 2 | 2 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -23.21% | -26.11% | -42.19% | - | - | - | - | - | - | - | - | - |
| 2025 | 1.68% | 8.02% | 7.19% | 27.46% | 20.92% | 43.83% | 35.90% | 81.97% | 60.61% | 25.04% | 11.53% | -7.33% |
| 2024 | 9.90% | 7.35% | -15.98% | 26.48% | 54.79% | 81.23% | 17.53% | 33.91% | 8.86% | -13.99% | -31.69% | -14.32% |
| 2023 | - | - | - | -37.84% | -44.82% | -55.86% | 16.67% | 49.21% | 20.63% | -9.17% | 1.82% | -0.54% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 12.14 | 11.91 | 9.22 | 13.15 | 16.41 | 10.02 | 5.32 | 7.40 | 6.96 | 5.18 | 5.75 | 7.25 | |||||
| Quick Ratio | 11.88 | 11.70 | 9.01 | 12.85 | 16.19 | 9.85 | 5.07 | 7.06 | 6.67 | 4.76 | 5.34 | 6.81 | |||||
| Working Capital | 100.39M | 104.38M | 81.63M | 79.33M | 88.49M | 95.43M | 31.62M | 39.17M | 35.65M | 25.84M | 33.98M | 41.69M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -1.53 | -1.43 | -1.53 | -5.00 | 1.18 | 19.24 | -3.27 | 7.47 | 6.44 | 0.22 | 0.21 | 0.19 | |||||
| Debt Ratio | 2.89 | 3.30 | 2.90 | 1.25 | 0.54 | 0.95 | 1.44 | 0.88 | 0.87 | 0.18 | 0.18 | 0.16 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.11 | 0.06 | 0.05 | 0.05 | 0.17 | 0.15 | 0.23 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Days Sales Outstanding TTM | 116.01 | 173.64 | - | 734.91 | 64.04 | 66.77 | 71.78 | 258.68 | - | - | - | - | |||||
| Receivables Turnover TTM | 3.15 | 2.10 | - | 0.50 | 5.70 | 5.47 | 5.08 | 1.41 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -13.57 | -31.29 | -32.37 | -12.23 | -4.06 | -22.52 | -21.67 | -13.77 | -16.90 | -18.04 | -21.33 | -17.17 | |||||
| Free Cash Flow Per Share TTM | -2.73 | -3.08 | -4.06 | -1.37 | -1.11 | -5.02 | -6.02 | -8.81 | -10.06 | -16.82 | -20.20 | -16.63 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Operating Profit Margin TTM | -385.28% | -573.75% | -1,210.58% | -1,055.63% | -205.44% | -223.06% | -239.69% | -266.71% | - | - | - | - | |||||
| Net Profit Margin TTM | -2,729.49% | -4,571.14% | -6,960.77% | -2,909.10% | -274.42% | -702.05% | -596.56% | -444.38% | - | - | - | - | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -8.79% | -35.61% | -67.37% | -63.96% | - | - | - | - | - | - | - | - | |||||
| Net Income Growth (1Y) | 807.15% | 319.27% | 280.76% | 135.93% | -35.20% | 117.44% | 47.68% | 27.31% | 41.34% | -11.28% | 19.55% | -30.45% | |||||
| EPS Growth (1Y) | 564.32% | 38.93% | 49.34% | -11.14% | -76.01% | 24.84% | 1.61% | -19.82% | -10.42% | -14.90% | 37.08% | -20.20% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -0.96 | -0.93 | -0.70 | -1.05 | -2.20 | -0.52 | -0.66 | -0.87 | -0.65 | -0.87 | -0.44 | -0.43 | |||||
| P/B TTM | -1.38 | -1.15 | -0.90 | -4.70 | 1.62 | 7.46 | -1.97 | 6.82 | 5.71 | 1.09 | 0.50 | 0.33 | |||||
| P/S TTM | 26.29 | 42.56 | 48.61 | 30.64 | 6.05 | 3.63 | 3.95 | 3.87 | - | - | - | - | |||||
| Market Cap | 302.65M | 318.94M | 169.00M | 110.44M | 76.36M | 42.30M | 42.09M | 38.67M | 34.62M | 32.72M | 18.97M | 14.94M | |||||
| Enterprise Value | 199.98M | 212.03M | 79.76M | 29.10M | -14.03M | -59.34M | 7.52M | 7.66M | -3.83M | 4.75M | -17.07M | -19.46M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -31.88M | -33.70M | -30.39M | -11.75M | -9.44M | -18.21M | -17.65M | -28.43M | -31.81M | -35.03M | -40.76M | -33.80M | |||||
| Net Debt | -102.67M | -106.91M | -89.25M | -81.34M | -90.39M | -101.65M | -34.57M | -31.01M | -38.45M | -27.98M | -36.04M | -34.40M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Surrozen, Inc./DE (SRZN) — SEC Financial Statements & Analysis
Surrozen, Inc./DE (SRZN) is a biological products, (no diagnostic substances) company, incorporated in DE. Surrozen, Inc./DE trades on Nasdaq as: SRZN, SRZNW. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Surrozen, Inc./DE reported a -8.79% year-over-year revenue growth, a Debt-to-Equity ratio of -1.53x, a Price-to-Sales (P/S) ratio of 26.29x (TTM), a Price-to-Book (P/B) ratio of -1.38x (TTM), at a market cap of $302.65M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -8.79%
- Debt To Equity
- -1.53x
- P/S TTM
- 26.29x
- P/B TTM
- -1.38x
- Market Cap
- $302.65M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Surrozen, Inc./DE in?
Surrozen, Inc./DE (SRZN) operates in the Biological Products, (No Diagnostic Substances) industry.
What is SRZN's market cap?
Surrozen, Inc./DE (SRZN) has a market capitalization of $302.65M as of 2026-06-30.
What exchange does SRZN trade on?
Surrozen, Inc./DE (SRZN) trades on the Nasdaq.
Where is Surrozen, Inc./DE incorporated?
Surrozen, Inc./DE is incorporated in DE.